Eli Lilly – SRK Analytics

Hands count US dollar bills, showcasing finance and cash handling concepts.

CVS Health Surpasses Financial Estimates and Raises Guidance on Insurance Unit Growth

CVS Health exceeds earnings forecasts and raises financial guidance, driven by a strengthening insurance division and a new collaboration with Eli Lilly.

Prasenjit Bhowmik September 3, 2026

A stunning aerial view of Indianapolis downtown skyline during sunset, capturing the vibrant cityscape.

Business Insights

Eli Lilly Raises 2026 Outlook After Strong Q2 Earnings and Surge in Zepbound Sales

Eli Lilly upgraded its 2026 financial outlook following a surge in Zepbound and Mounjaro sales, easily topping quarterly Wall Street estimates.

Prasenjit Bhowmik September 3, 2026

Emerging Market

Novo Nordisk Sues Eli Lilly Over Alleged Misleading GLP-1 Advertising

Danish pharmaceutical giant Novo Nordisk filed a federal lawsuit against rival Eli Lilly, alleging that the American drugmaker engaged in false and deceptive advertising regarding its popular GLP-1 class of…

Prasenjit Bhowmik July 25, 2026

Market

Eli Lilly-Backed Scribe Therapeutics Surges 67% Following $128.7 Million Upsized IPO

On Thursday, Scribe Therapeutics surged 67% during its market debut on the Nasdaq after raising $128.7 million in an upsized initial public offering, signaling renewed investor enthusiasm for early-stage genetic…

Prasenjit Bhowmik July 25, 2026

Emerging Market

Eli Lilly Targets 2027 Approval for Next-Generation Triple-Agonist Obesity Drug Retatrutide

Eli Lilly plans to seek approval for its next-generation obesity drug retatrutide by 2027 following highly successful late-stage clinical trials.

Prasenjit Bhowmik July 24, 2026

Business Insights

Eli Lilly’s Next-Generation Weight-Loss Drug Clears Critical Heart Safety Hurdle

Pharmaceutical giant Eli Lilly & Co. announced this week that its experimental, next-generation weight-loss therapy demonstrated no overall increase in cardiovascular risk in a major clinical evaluation, successfully clearing a…

Prasenjit Bhowmik July 23, 2026

Emerging Market

FDA Launches PreCheck Pilot to Accelerate Pharmaceutical Manufacturing Approvals

The U.S. Food and Drug Administration (FDA) has officially launched its PreCheck Pilot Program, selecting seven major pharmaceutical companies—including industry giants Eli Lilly and Regeneron—to participate in a new initiative…

Prasenjit Bhowmik June 29, 2026